Literature DB >> 4568298

Symptomatic volunteers: another patient dimension for clinical trials.

B Brauzer, B J Goldstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4568298     DOI: 10.1002/j.1552-4604.1973.tb00258.x

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN: 0021-9754


× No keyword cloud information.
  4 in total

Review 1.  Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity.

Authors:  Mark Zimmerman; Matthew Multach; Emily Walsh; Lia K Rosenstein; Douglas Gazarian; Heather L Clark
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

2.  A single dose study of nabilone, a synthetic cannabinoid.

Authors:  R M Glass; E H Uhlenhuth; F W Hartel; C R Schuster; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.

Authors:  Mark Zimmerman; Carolina Guzman Holst; Heather L Clark; Matthew Multach; Emily Walsh; Lia K Rosenstein; Douglas Gazarian
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

4.  From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient Samples.

Authors:  R Bruce Lydiard; Philip Perera; Evan Batzar; Cathryn M. Clary
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.